Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration
- 218 Downloads
Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS), performed using closed-abdomen technique (CAT), may affect intraabdominal pressure (IAP). High IAP may increase postoperative complications due to decreased venous return and hypoperfusion to vital organs. Elevated core body temperature (CBT) may cause multiorgan dysfunction. Low IAP or CBT could result in suboptimal HIPEC and potentially translate into early disease recurrence. The aim of the present study is to identify possible correlations between IAP or CBT and postoperative complications.
Patients and Methods
Continuous intraabdominal pressure measurement was performed by intraabdominal catheter. Inflow temperature was set at 44 °C, and mean perfusate temperature was 42 °C. CBT was measured continuously in the distal esophagus. We compared the rate of postoperative complications between the low IAP group (2–10 mmHg, n = 28), target IAP group (10–20 mmHg, n = 71), and high IAP group (20–34 mmHg, n = 16) as well as with CBT as a continuous variable.
115 patients were included in the study. There was no difference between IAP groups in terms of age, gender, primary diagnosis, operative peritoneal cancer index, CBT, or operative time. There was no correlation between IAP and postoperative complications or with prolonged hospital stay. On multivariate analysis, elevated mean CBT was a positive predictor of postoperative complications (p = 0.035).
IAP level during closed-abdomen technique HIPEC is not associated with postoperative complications. However, elevated CBT may increase postoperative complications.
The authors have no commercial disclosures relevant to this work.
- 1.Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM, Francescutti VA. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol. 2016; https://doi.org/10.1245/s10434-016-5692-3.
- 4.Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, Chauffert, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol. 2010;17(7):1957–63. https://doi.org/10.1245/s10434-010-0937-z.CrossRefPubMedGoogle Scholar
- 5.Elias D, Franc G, Boutitie F, Quenet F, Bereder JM, Baudouin M, Lorimier G. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. 2016;28(1):63–68. https://doi.org/10.1200/jco.2009.23.9285.
- 6.Elias D, Antoun S, Goharin A, Otmany AE, Puizillout JM, Lasser P. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig. 2000;1(5):0–1.Google Scholar
- 8.Kajdi M, Beck-schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;12(1):1–9. https://doi.org/10.1186/1477-7819-12-136.CrossRefGoogle Scholar
- 10.Malbrain MLNG, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, Waele JD, Balogh H, et al. Results from the International Conference of experts on intra-ABDOMINAL hypertension and abdominal compartment syndrome. I. definitions. Intensive Care Med. 2006;32(11):1722–32. https://doi.org/10.1007/s00134-006-0349-5.CrossRefPubMedGoogle Scholar
- 12.Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Schaaf L, Kuip H, Zopf W, Winter S, Munch M, Murdter T, Thon KP, et al. A temperature of 40 °C appears to be a critical threshold for potentiating cytotoxic chemotherapy in vitro and in peritoneal carcinomatosis patients undergoing HIPEC. Ann Surg Oncol. 2015:758–65. https://doi.org/10.1245/s10434-015-4853
- 18.Lepock JR. How do cells respond to their thermal environment? Int J Hyperthermia. 2005;20:8. https://doi.org/10.1080/02656730500307298
- 21.Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, Beltramo JL, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244(1):106–112. https://doi.org/10.1097/01.sla.0000218089.61635.5f.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15(1):339–44. https://doi.org/10.1245/s10434-007-9571-9.CrossRefPubMedGoogle Scholar
- 24.Malbrain MLNG. Different techniques to measure intra-abdominal pressure (IAP): time for a critical re-appraisal. Appl Physiol Intensive Care Med 2 Physiol Rev Ed. 2012:13–27. https://doi.org/10.1007/978-3-642-28233-1_2.